Nurix Therapeutics (NRIX) News Today $9.18 -0.54 (-5.56%) Closing price 04:00 PM EasternExtended Trading$9.25 +0.07 (+0.75%) As of 05:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRIX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Nurix Therapeutics (NASDAQ:NRIX) Price Target Lowered to $15.00 at Morgan Stanley5 hours ago | marketbeat.comNurix Therapeutics Reports Increased Losses Amid R&D ExpansionOctober 13 at 12:10 AM | tipranks.comNurix Therapeutics (NASDAQ:NRIX) Shares Down 4.4% - Should You Sell?October 13 at 12:51 PM | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesOctober 13 at 2:37 AM | marketbeat.comOppenheimer Maintains Nurix Therapeutics (NRIX) Outperform RecommendationOctober 12 at 7:56 PM | msn.comNurix Therapeutics (NRIX): Losses Worsen 21.7% Annually, Reinforcing Profitability Concerns Despite Growth NarrativeOctober 11 at 2:20 PM | finance.yahoo.comNurix Therapeutics (NASDAQ:NRIX) Shares Gap Down Following Weak EarningsOctober 11 at 10:38 AM | marketbeat.comNurix: Bexobrutideg Advancement Presses Forward With H2 2025 MilestonesOctober 11 at 9:06 AM | seekingalpha.comNurix Therapeutics (NASDAQ:NRIX) Announces Quarterly Earnings ResultsOctober 11 at 7:36 AM | marketbeat.comWall Street Zen Downgrades Nurix Therapeutics (NASDAQ:NRIX) to Strong SellOctober 11 at 2:50 AM | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Trading 8.7% Higher - Still a Buy?October 10, 2025 | marketbeat.comBreaking Down Nurix Therapeutics: 5 Analysts Share Their ViewsOctober 10, 2025 | benzinga.comPiper Sandler Maintains Nurix Therapeutics (NRIX) Overweight RecommendationOctober 10, 2025 | msn.comNurix Therapeutics (NASDAQ:NRIX) Receives Sell (D-) Rating from Weiss RatingsOctober 10, 2025 | marketbeat.comNurix Therapeutics price target lowered to $28 from $30 at OppenheimerOctober 10, 2025 | msn.comNurix Therapeutics reports Q3 EPS ($1.03), consensus (85c)October 9, 2025 | msn.comNurix Therapeutics shares tumble 9% on wider-than-expected Q3 loss, revenue missOctober 9, 2025 | investing.comNurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate UpdateOctober 9, 2025 | globenewswire.comNurix Therapeutics (NRIX) to Release Earnings on FridayOctober 8, 2025 | americanbankingnews.comNurix Therapeutics (NRIX) Projected to Post Quarterly Earnings on FridayOctober 3, 2025 | marketbeat.comVoya Investment Management LLC Lowers Holdings in Nurix Therapeutics, Inc. $NRIXSeptember 30, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Shares Up 4.6% - Time to Buy?September 26, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Shares Up 6.5% - Time to Buy?September 18, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Consensus Recommendation of "Moderate Buy" from AnalystsSeptember 18, 2025 | marketbeat.comNurix Therapeutics presents data from GS-6791September 17, 2025 | msn.comNurix Therapeutics Presents Preclinical Data from Novel IRAK4 Degrader, GS-6791, Demonstrating Potent Inhibition of IL-1 and IL-36 in Vitro and Efficacy in a Model of DermatitisSeptember 17, 2025 | globenewswire.comGoldman Sachs Group Inc. Raises Stock Holdings in Nurix Therapeutics, Inc. $NRIXSeptember 17, 2025 | marketbeat.comNurix Therapeutics, Inc. (NRIX) Presents At Baird Global Healthcare Conference 2025 (Transcript)September 12, 2025 | seekingalpha.comNurix Therapeutics, Inc. (NRIX) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)September 12, 2025 | seekingalpha.comNurix Therapeutics (NASDAQ:NRIX) Trading Down 6.5% - What's Next?September 11, 2025 | marketbeat.comNurix Therapeutics, Inc. (NRIX) Presents At H.C. Wainwright 27th Annual Global Investment Conference TranscriptSeptember 11, 2025 | seekingalpha.comNurix Therapeutics, Inc. (NRIX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comParkman Healthcare Partners LLC Sells 181,752 Shares of Nurix Therapeutics, Inc. $NRIXSeptember 8, 2025 | marketbeat.comCinctive Capital Management LP Cuts Position in Nurix Therapeutics, Inc. $NRIXSeptember 8, 2025 | marketbeat.comNurix Therapeutics, Inc. (NRIX) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 - SlideshowSeptember 5, 2025 | seekingalpha.comRedmile Group LLC Sells 140,700 Shares of Nurix Therapeutics, Inc. $NRIXSeptember 4, 2025 | marketbeat.comVestal Point Capital LP Has $13.37 Million Stock Position in Nurix Therapeutics, Inc. $NRIXSeptember 4, 2025 | marketbeat.comInvesco Ltd. Has $1.40 Million Stake in Nurix Therapeutics, Inc. $NRIXSeptember 3, 2025 | marketbeat.comNurix Therapeutics, Inc. $NRIX Shares Sold by Driehaus Capital Management LLCSeptember 2, 2025 | marketbeat.com74,060 Shares in Nurix Therapeutics, Inc. $NRIX Purchased by Walleye Capital LLCSeptember 2, 2025 | marketbeat.comNuveen LLC Invests $2.01 Million in Nurix Therapeutics, Inc. $NRIXSeptember 1, 2025 | marketbeat.comNurix Therapeutics, Inc. $NRIX Shares Acquired by Tema Etfs LLCAugust 31, 2025 | marketbeat.comNurix Therapeutics, Inc. $NRIX Shares Acquired by Russell Investments Group Ltd.August 30, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Stock Rating Upgraded by Baird R WAugust 29, 2025 | marketbeat.comNurix Therapeutics to Participate in Upcoming Investor ConferencesAugust 28, 2025 | globenewswire.comNurix Therapeutics, Inc. $NRIX Shares Sold by Affinity Asset Advisors LLCAugust 28, 2025 | marketbeat.comVanguard Group Inc. Acquires 69,856 Shares of Nurix Therapeutics, Inc. $NRIXAugust 28, 2025 | marketbeat.comNurix Therapeutics, Inc. $NRIX Shares Sold by Wellington Management Group LLPAugust 27, 2025 | marketbeat.comNurix Therapeutics, Inc. $NRIX Shares Bought by T. Rowe Price Investment Management Inc.August 26, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Given Average Rating of "Moderate Buy" by BrokeragesAugust 26, 2025 | marketbeat.com Get Nurix Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NRIX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NRIX Media Mentions By Week NRIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRIX News Sentiment▼0.060.75▲Average Medical News Sentiment NRIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRIX Articles This Week▼216▲NRIX Articles Average Week Get the Latest News and Ratings for NRIX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Nurix Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies OGN News MOR News KNSA News HCM News TARS News BEAM News CDTX News CPRX News MLYS News ALVO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRIX) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredWhy Wall Street is piling into the “Debasement Trade”Wall Street is piling into what insiders are calling the “Debasement Trade” — and according to former Goldman ...Stansberry Research | Sponsored2 Nobel Prize winners warn of once-in-a-generation wealth shift…An unstoppable force is reshaping America — one so powerful it’s already disrupting how we work, invest, and l...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nurix Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
